CDNA CareDx, Inc.
$72.13▲ +2.27%
Healthcare
Other
After hours
$72.43▲ +0.42%
Oct 28, 7:28 PM ET
Volume 905.9K
Avg Volume (10D) 1.16M
Key Metrics & Fundamentals
Market Cap
$3.73B
P/E Ratio
34.7
Div Yield
0.00%
52W Range
14.23 - 73.43
% vs 50 MA
23.05%
% vs 200 MA
118.25%
RSI-14
68.7
MACD Histogram
+0.0200
Beta (1Y vs SPY)
1.43
Free Cash Flow
$28.75M
Gross Rev
$131.95M
Gross Profit
$96.98M
EBITDA
-$108.66M
COGS
$34.97M
Operating Exp
$96.73M
Operating Income
$257,000
EBIT
$257,000
Pretax Income
$114.52M
Net Income
$110.64M
EPS (Diluted)
2.07
Price & Volume History
Loading chart…
Recent News

CareDx (CDNA) After Kidney Week Data Is The Story Already Priced In
Simply Wall St. · Oct 27, 2026 7:16 PM ET

CareDx to Report Q3 Earnings: Transplant Testing Growth in Focus
Zacks · Oct 26, 2026 8:58 AM ET

CareDx Announces New KOAR Data Linking Elevated AlloSure® Kidney to Nearly 3-Fold Higher Risk of Adverse Graft Outcomes in Patients with Borderline Rejection or TCMR at ASN Kidney Week 2026
Business Wire · Oct 22, 2026 7:05 AM ET

CareDx to Report Third Quarter 2026 Financial Results on October 29, 2026
Business Wire · Oct 15, 2026 4:01 PM ET

CareDx (CDNA) Stock Gets Fair Value Bump After Reimbursement And Analyst Target Changes
Simply Wall St. · Oct 9, 2026 8:20 PM ET

Consumer Confidence Falls Amid Ongoing Geopolitical Tensions: 4 Picks
Zacks · Sep 30, 2026 7:29 AM ET

CareDx (CDNA) Stock Jumps 13.0%: Will It Continue to Soar?
Zacks · Sep 25, 2026 3:18 AM ET
CareDx +14% on Fresh $74 Analyst Price Target
TIKR · Sep 24, 2026 2:02 PM ET

Zacks.com featured highlights include CareDx, Ciena, Celestica, Materion and MACOM Technology Solutions
Zacks · Sep 24, 2026 5:39 AM ET

5 Top-Ranked High-Efficiency Stocks With Strong Profit Potential
Zacks · Sep 23, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CDNA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.